| Medical Care Center Of Cheshire,inc | |
|
430 Highland Ave Cheshire CT 06410-2562 | |
| (203) 271-3132 | |
| (203) 271-3940 |
| Full Name | Medical Care Center Of Cheshire,inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 430 Highland Ave, Cheshire, Connecticut |
| Authorized Official Name and Position | Husam Bahgat Shitia (PRESIDENT) |
| Authorized Official Contact | 2032713132 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Medical Care Center Of Cheshire,inc 430 Highland Ave Cheshire CT 06410-2562 Ph: (203) 271-3132 | Medical Care Center Of Cheshire,inc 430 Highland Ave Cheshire CT 06410-2562 Ph: (203) 271-3132 |
| NPI Number | 1881793511 |
|---|---|
| Provider Enumeration Date | 09/21/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 8426243668 |
|---|---|
| Medicare Enrollment ID | O20101112000620 |
News Archive
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the CE marking and launch of the AmplideX DM1 Dx Kit, which simplifies the analysis of repeat expansions within the DMPK gene and is intended to aid in the diagnosis of Myotonic Dystrophy Type I (DM1), also known as Steinert's Disease.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881793511 | NPI | - | NPPES |
| 718079 | Other | CT | CONNECTICARE |
| G29889 | Other | CT | UNITED HEALTH CARE |
| 619002 | Other | CT | AETNA |
| 0V0544 | Other | CT | HEALTHNET |
| 010034996CT01 | Other | CT | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0000X | Internal Medicine - Adolescent Medicine | 034996 (Connecticut) | Primary |
| 207RA0000X | Internal Medicine - Adolescent Medicine | ME72340 (Florida) | Secondary |
| Provider Name | Husam Bahgat Shitia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972604528 PECOS PAC ID: 9335334572 Enrollment ID: I20101112000679 |
News Archive
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the CE marking and launch of the AmplideX DM1 Dx Kit, which simplifies the analysis of repeat expansions within the DMPK gene and is intended to aid in the diagnosis of Myotonic Dystrophy Type I (DM1), also known as Steinert's Disease.
› Verified 6 days ago
News Archive
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.
Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the CE marking and launch of the AmplideX DM1 Dx Kit, which simplifies the analysis of repeat expansions within the DMPK gene and is intended to aid in the diagnosis of Myotonic Dystrophy Type I (DM1), also known as Steinert's Disease.
› Verified 6 days ago
Center For Holistic Healthcare, Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 120 Contour Dr, Cheshire, CT 06410 Phone: 203-466-9211 | |
On Call Medical Care Ct Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 405 Maple Ave Ste 1, Cheshire, CT 06410 Phone: 516-615-8586 | |
Mount Carmel Internal Medicine And Geriatrics Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 680 S Main St, Suite 205, Cheshire, CT 06410 Phone: 203-699-9898 Fax: 203-250-7878 | |
Grand Medical Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 515 Higgins Rd, Cheshire, CT 06410 Phone: 914-374-3468 | |
Ana Maria Apoltan Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1157 Highland Ave, Cheshire, CT 06410 Phone: 203-699-8880 Fax: 203-699-8818 | |
J.t. Bristol, M.d., Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 680 S Main St, Suite 102, Cheshire, CT 06410 Phone: 860-818-6668 | |
Maud Ward, M.d. Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 366 S Main St, Cheshire, CT 06410 Phone: 203-272-0333 Fax: 203-272-0332 |